The Patent Finder

Methylgene ULC

Also on record
Records under this name other than patents Methylgene ULC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 8 of 8 · Back to Methylgene ULC

PatentTitleStatus Expires Confidence
US 8,389,541Inhibitors of Protein Tyrosine Kinase Activity
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,569,503Processes and Intermediates for Preparing Fused Heterocyclic Kinase Inhibitors
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,846,927Inhibitors of Protein Tyrosine Kinase Activity
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 9,018,378Processes and Intermediates for Preparing Fused Heterocyclic Kinase Inhibitors
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 8,404,846Inhibitors of Protein Tyrosine Kinase Activity
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 8,093,264Fused Heterocycles as Inhibitors of VEGF Receptor and HGF Receptor Signaling
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,907,091Processes and Intermediates for Preparing Fused Heterocyclic Kinase Inhibitors
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,329,726Inhibitors of VEGF Receptor and HGF Receptor Signaling
Formerly held
Term ended
Term ended May 19, 2026 · High confidence
Term endedTerm ended May 19, 2026High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited